Abstract
Drug rash with eosinophilia and systemic symptoms (DRESS), or drug-induced hypersensitivity syndrome (DiHS), is a rare, but severe adverse drug reaction. Rapid diagnosis and removal of the causative drug are critical to treatment. With the increasing use of targeted therapies, it is important to be aware of these drugs as potential causes of DRESS/DiHS. Imatinib is a tyrosine kinase inhibitor used in the treatment of various malignancies, hypereosinophilic syndrome (HES), and other eosinophilic disorders. We report a rare case of imatinib-induced DRESS/DiHS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
